Bio-based alkyl glyceryl ether and method of preparation and use thereof
Bio-based alkyl glyceryl ethers synthesized from plant-derived materials address the sustainability concerns of petrochemical-derived counterparts, offering effective microbial protection and improved sustainability in personal care products.
Patent Information
- Application Number
- KR1020227044572
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-05-22
- Filing Date
- 2021-05-24
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2041-05-24
AI Technical Summary
Existing alkyl glyceryl ethers are synthesized from non-renewable petrochemical feedstocks, making them unsustainable and less desirable for consumer products, despite their useful properties as surfactants and antimicrobial agents.
Development of bio-based alkyl, alkenyl, and alkynyl glyceryl ethers derived from renewable plant-based feedstocks, synthesized through a process involving bio-based alcohols, epihalohydrins, and hydrolysis, which are used in formulations to provide antimicrobial protection and improve product sustainability.
The bio-based glyceryl ethers offer sustainable alternatives with equivalent performance to petrochemical-derived counterparts, enhancing consumer appeal by being entirely renewable and providing effective microbial protection in personal care and other products.
Smart Images

Figure 112022136699899-PCT00067_ABST
Abstract
Description
Technology Field
[0001] Cross-reference regarding related applications
[0002] This application claims the benefit of the filing date of U.S. provisional application No. 63 / 029,281 filed on May 22, 2020, the contents of which are incorporated herein by reference in whole.
[0003] Field of invention
[0004] The present invention relates to bio-based alkyl glyceryl ether compounds and compositions, formulations containing compounds and compositions, methods for preparing and using compounds, compositions and formulations, and particularly applications thereof including cosmetic applications. Background Technology
[0005] Alkyl glyceryl ethers are very useful compounds in a wide range of industries due to their mostly nonionic amphiphilic properties. 1 Alkyl glyceryl ethers are particularly useful in formulations of cosmetic and / or personal care products in which these compounds can function as surfactants, cleansing agents, foam boosters, emulsifiers, skin conditioning agents, moisturizers, emollients, and deodorants.
[0006] Branched alkyl glyceryl ethers, such as 2-ethylhexylglycerin, isodecyl glyceryl ether, and isostearyl glyceryl ether, are particularly useful due to their branched alkyl chains that impart greater fluidity at low temperatures (e.g., many are viscous fluids below 5°C) and can improve the processability of formulations and the compatibility of various excipients. For example, 2-ethylhexylglycerin (EHG, Fig. 1) has a melting point of -13°C and is a pourable liquid at room temperature, whereas, 3 The corresponding alkyl glyceryl ether with a linear alkyl chain (i.e., caprylyl glyceryl ether (indicated below)) is a solid at room temperature with a reported melting point of about 69°C. 2
[0007]
[0008] Medium-chain branched alkyl groups, namely branched alkyl glyceryl ethers having 4 to 10 carbon atoms, are particularly useful. EHGs, the so-called medium-chain terminal diols, are well known for their ability to impair the membrane integrity of microorganisms. This membrane-disrupting ability is indicated by an octanol-water partition coefficient (log K) of 1.9. ow This is attributed to the amphiphilic properties of EHG, which are characterized by the value of ). Due to these properties of EHG, it protects aqueous formulations such as cosmetics, toiletries, and pharmaceuticals from microbial contamination and is a useful ingredient as an odor control agent in deodorizers.
[0009] The primary synthesis route for EHG is shown in Reaction Scheme 1-3 below. As shown in Reaction Scheme 1, propylene is generally used as a feedstock for the production of 2-ethylhexanol.
[0010] Reaction Equation 1
[0011] As shown in Reaction Scheme 2, propylene is also a common feedstock for ECH synthesis.
[0012] Reaction Equation 2
[0013] Finally, Reaction Scheme 3 shows the general synthesis route of EHG, which involves etherifying 2-ethylhexanol with epichlorohydrin (ECH) and then in situ hydrolyzing the epoxide to produce a 1,2-diol.
[0014] Reaction Equation 3
[0015] However, as indicated above, the well-known synthesis route for EHG generally relies on non-renewable feedstock propylene obtained from oil or natural gas. As such, EHG is not considered "natural" or "sustainable" by consumers, and incorporating EHG into consumer products is becoming increasingly undesirable. The problem to be solved
[0016] There remains a need for bio-based alkyl, alkenyl and / or alkynyl glyceryl ethers produced from sustainable and renewable plant-based feedstocks. means of solving the problem
[0017] The present invention relates to a bio-based compound of formula (I):
[0018]
[0019] In the formula, R1 is a branched C6 to C16 alkyl, alkenyl or alkynyl group; and n is 1 to 3; substantially all carbons present in the compound of formula (I) are bio-based.
[0020] In some embodiments, the present invention relates to a compound of formula (I) where n is 1 and a composition comprising the same. Such a composition may optionally comprise one or more compounds of formula (I) where n is 2 and / or n is 3.
[0021] In some embodiments, in the compound of formula (I), the R1-O bond is on the secondary carbon of R1. In some embodiments, R1 is a branched C6 to C6 containing at least one methyl branch. 16 It is an alkyl.
[0022] In some embodiments, R1 is branched C6 to C 12 It is an alkyl, alkenyl, or alkynyl. In some embodiments, R1 is a branched C6 to C 10 It is an alkyl, alkenyl, or alkynyl. In some embodiments, R1 is a branched C8 alkyl, alkenyl, or alkynyl. In some embodiments, the compound of formula (I) is 1-methylheptylglycerin.
[0023] The present invention also relates to a composition comprising one or more compounds of formula (I). In some embodiments, the composition of the present invention has R1 branched C6 to C 10It comprises at least one compound of formula (I) in which n is 1, wherein the compound is alkyl, alkenyl, or alkynyl. In some embodiments, the composition of the present invention comprises R1 being a branched C6 to C 16 A first compound of formula (I) which is alkyl, alkenyl, or alkynyl and n is 1; and R1 is a branched C6 to C 10 It comprises a second compound of formula (I) in which n is 1, wherein R1 is alkyl, alkenyl, or alkynyl; and the first and second compounds of formula (I) are not identical. In some embodiments, the composition of the present invention comprises a compound of formula (I) in which R1 is a methyl-branched C6 to C16 alkyl, alkenyl, or alkynyl; and the methyl branched compound is present in a ratio of 10:1 or greater relative to the concentration of the ethyl branched compound. In some embodiments, the composition of the present invention comprises a methyl-branched C6 to C16 alkyl having a single methyl branch. 16 The compound is alkyl, and the compound comprises a compound of formula (I) comprising at least 95 weight percent of all compounds of formula (I) present in the composition. In some embodiments, the composition of the present invention comprises 1-methylheptylglycerin (MHG). In some embodiments, MHG is the only compound of formula (I) present in the composition.
[0024] In some embodiments, the composition of the present invention further comprises a solvent or a diluent. In some embodiments, the composition of the present invention is silicon-free.
[0025] The present invention also relates to a process for manufacturing a compound of formula (I):
[0026]
[0027] In the formula, R1 is a branched C6 to C 16 It is alkyl, alkenyl, or alkynyl; n is 1 to 3, and the process is bio-based branched C6 to C in the presence of a catalyst 16It includes contacting an alcohol, alkenol, or alkinol with a bio-based C3 epihalohydrin or oxiranyl alcohol and then hydrolyzing it.
[0028] In some embodiments, the process of the present invention is a bio-based branched C6 to C 16 The use of alcohols, alkenols, or compounds in which the -OH group of the alkenol is not located at a terminal position. In some embodiments, the process of the present invention is branched C6 to C 10 Alcohol, alkenol or alkenol, or branched C6 to C 10 It includes using bio-based alcohols that are alcohols, alkenols, or alkinols, or the bio-based alcohol is 2-octanol.
[0029] In some embodiments, the process of the present invention comprises a catalyst which is boron trifluoride or tin tetrachloride. In some embodiments, the bio-based epihalohydrin is epichlorohydrin. In some embodiments, the bio-based oxiranyl alcohol is glycidol.
[0030] The present invention also relates to a formulation comprising: (i) a bio-based compound of formula (I):
[0031]
[0032] (In the formula, R1 is branched C6 to C 16 alkyl, alkenyl, or alkynyl group; n is 1 to 3; substantially all carbons present in the compound of formula (I) are bio-based; and (ii) at least one other bio-based component.
[0033] In some embodiments, the formulation is a personal care product or an ingredient of a personal care product selected from the following: a cosmetic, conditioner for hair, nails, skin or fabrics, shampoo, hair styling product, oil or wax for grooming facial hair, permanent wave liquid, hair dye, face and / or body wash, makeup remover, cleansing lotion, emollient lotion or cream, bar soap, liquid soap, shaving cream, foam, or gel, sunscreen, gel, lotion or cream for treating sunburn, deodorant or antiperspirant, moisturizing gel, shaving foam, face powder, foundation, lipstick, blush, eyeliner, anti-wrinkle or anti-aging cream, eyeshadow, eyebrow pencil, mascara, mouthwash, toothpaste, oral care product, skin cleansing product, fabric cleansing product, wash product, hair or fur cleansing product, or skin lotion or moisturizer.
[0034] In some embodiments, the formulation comprises a compound of formula (I) which is MHG.
[0035] Ingredients suitable for use with the formulations of the present invention include, but are not limited to, water, surfactants, emollients, moisturizers, conditioning agents, chelating agents, activators, bleaching or whitening agents, pH adjusters, fragrances, colorants, exfoliants, antioxidants, plant components, mica, smectite, thickeners, cannabinoids, oils, dyes, waxes, amino acids, nucleic acids, vitamins, hydrolyzed proteins and their derivatives, glycerin and its derivatives, enzymes, anti-inflammatory and other agents, biocides, antifungals, preservatives, antioxidants, UV absorbers, dyes and pigments, preservatives, UV blocking agents, antiperspirant agents, oxidizing agents, pH balancing agents, moisturizers, peptides and their derivatives, anti-aging agents, hair growth promoters, anti-cellulite agents, and combinations thereof. In some embodiments, the ingredients are also bio-based.
[0036] In some embodiments, the compound of formula (I) is present at a concentration of about 0.05 wt% to about 10 wt% or about 0.5 wt% to about 2.5 wt% of the formulation. In some embodiments, the formulation has a pH of about 2 to about 10, or about 3 to about 7.5.
[0037] In some embodiments, the formulation comprises an oil-in-water emulsion. In some embodiments, the formulation comprises a micelle solution comprising water and at least one surfactant. In some embodiments, the formulation is silicone-free.
[0038] The present invention also relates to a method for attenuating microbial contamination comprising blending the following: (i) an effective amount of a bio-based compound of formula (I):
[0039]
[0040] (In the formula, R1 is branched C6 to C 16 (ii) an alkyl, alkenyl, or alkynyl group, where n is 1 to 3, and substantially all carbons present in the compound of formula (I) are bio-based, (ii) at least one other component.
[0041] In some embodiments, the process of the present invention for attenuating microbial contamination comprises blending an effective amount of a compound of formula (I) with at least one other ingredient suitable for use in formulations as described herein, which include pharmaceutical products, food processing products, and any other consumer products requiring preservation. In some embodiments, at least one other ingredient is bio-based.
[0042] In some embodiments, the method of the present invention for attenuating microbial contamination comprises blending a compound of formula (I) at a concentration of about 0.05% to about 10% by weight, about 0.5% to about 2.5% by weight, or about 0.5% to about 1.5% by weight of a composition or formulation.
[0043] In some embodiments, the compositions, formulations, and products containing the same of the present invention, as well as the methods related thereto, further comprise a booster. Boosters suitable for use with the compositions, formulations, products, and methods of the present invention include, but are not limited to, medium-chain diols, medium-chain polyols, chelating agents, and combinations thereof.
[0044] Chelating agents suitable for use with the compositions, formulations, products, and methods of the present invention are C6 to C 10 Alkylhydroxamic acid or its alkylhydroxamate salt, tetrasodium glutamate diacetate, phytic acid or its salt, gluconic acid or its salt, galacturonic acid or its salt, galactaric acid or its salt, and combinations thereof are included but not limited thereto. In some embodiments, the chelating agent is caprylhydroxamic acid, the hydroxamate salt of caprylhydroxamic acid, or a combination thereof. Brief explanation of the drawing
[0045] FIG. 1 provides a graphic representation of the “Soaping Score” as a function of the “Rub Number,” and the experimental details thereof are provided in Example 18 and Comparative Examples 8 to 10 of the present invention. Specific details for implementing the invention
[0046] In particular, before describing the compounds, compositions, and methods of the present invention, it should be understood that the present invention is not limited thereto, as the specific processes, compositions, or methodologies described may vary. It should be understood that the terms used herein are merely for describing specific versions or embodiments and are not intended to limit the scope of the present invention, which is limited only by the appended claims. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as generally understood by those skilled in the art. Any method and material similar or equivalent to those described herein may be used to practice or test embodiments of the present invention, but preferred methods, apparatus, and materials are described hereafter. All publications mentioned herein are incorporated by reference in their entirety. Nothing in this specification should be construed as an acknowledgment that the present invention is not qualified to precede such disclosures by prior art.
[0047] It should also be noted that, as used herein, the singular form includes plural objects unless the context clearly indicates otherwise. Accordingly, for example, a reference to "cell" refers to one or more cells and equivalents thereof known to those skilled in the art.
[0048] Unless otherwise specified, "%" may mean weight or volume percentage.
[0049] "Acceptable for cosmetic use" means suitable for use in contact with the skin without excessive toxicity, incompatibility, instability, irritation, or allergic reactions.
[0050] Where applicable, chemicals are designated by their INCI names in accordance with the guidelines of the International Nomenclature of Cosmetic Ingredients. Additional information, including suppliers and trademarks, is available in the literature [ International Cosmetic Ingredient Dictionary and Handbook[The 16th Edition, published by the Personal Care Products Council, Washington, DC] and can be found online at the Personal Care Products Council On-Line INFOBASE (http: / / online.personalcarecouncil.org).
[0051] The branched alkyl, alkenyl, and alkynyl glyceryl ether compounds of the present invention (collectively "BAGE") are bio-based. Accordingly, the bio-based BAGE compounds of the present invention contain up to 100% renewable carbon (i.e., carbon from plant sources) and are manufactured using bio-based (i.e., renewable) starting materials instead of traditional petrochemical-derived carbon feedstocks. The bio-based BAGE compounds of the present invention provide all the benefits of petrochemical-derived BAGE compounds, along with the advantages of improved sustainability and added consumer appeal, as consumers continue to seek more natural and sustainable products in the market.
[0052] The bio-based carbon content of compounds, compositions, or formulations can be measured by radiocarbon dating to determine the relative age of materials, particularly those composed of organic (i.e., carbon-containing) materials. Radiocarbon 14 It is an unstable isotope of carbon known as C. 14 C emits radiation energy in the form of beta particles at a very constant rate and ultimately becomes more stable 14 It is an unstable isotope that decays into N (i.e., the half-life of radiocarbon is 5,730 years). Because petroleum-based (i.e., petrochemical-derived) feedstocks originate from plants and animals buried millions of years ago, the radiocarbon of the feedstocks (i.e., 14C) was lost due to radioactive decay. The ASTM international standard provides test standards for determining the authenticity of "bio-based compounds" using radiocarbon, which can be found in ASTM D6866-16. This standard distinguishes between "old carbon," i.e., carbon derived from sources originating from fossil fuels or petroleum and petrochemicals, and new carbon. From recent or current biomass 14 Since the amount of C is known, the proportion of carbon in renewable resources can be estimated from a total organic carbon analysis, which provides the data necessary to determine whether a compound is truly derived from "natural" and / or "sustainable" ("renewable") feedstock sources or, conversely, from "old" sequestered compounds (i.e., petrochemical-derived or petroleum-based sources). The use of petroleum-based or often labeled fossil-based feedstocks is generally accepted as unsustainable, that is, "old carbon" from petroleum or other fossil fuels is not sustainable, is not a renewable feedstock, and is not considered "natural" and / or "sustainable" among those skilled in the art.
[0053] Bio-based carbon content can also be determined by isotope analysis methods, such as mass spectrometry, to evaluate, for example, the ratios of carbon-12 / carbon-13 and / or hydrogen-1 / hydrogen-2. These tests are available through various analytical service laboratories, are faster and more cost-effective, and provide more detailed information compared to radiocarbon testing methods. Stable isotope analysis is based on the principle of the kinetic isotope effect. The latter effect is well known to those skilled in the art of chemical kinetics. In the broadest sense, the heavy isotopes of a particular element react more slowly than their lighter equivalents (e.g., carbon-12 as opposed to carbon-13). Therefore, when plants incorporate carbon dioxide into biomass, the ratio of carbon-12 to carbon-13 will depend on the type of chemistry used by the plant to create biomass (e.g., whether the plant follows the C3 or C4 photosynthetic pathway). This generally refers to δ 13 C / 12 C ratio (i.e., δ 13 It is reported as C) and refers to current carbon dioxide standards. In addition, similar isotope kinetic effects are observed when water is incorporated into new biomass, and this is δ 2 H / 1 H ratio (i.e., δ 2 Measured with H). δ 13 C and δ 2 By using combinations of H ratios, a person familiar with the relevant technical field can easily distinguish and verify the characteristics of the feedstock used to prepare the preservative product being analyzed (i.e., whether it is of petrochemical origin or derived from recently living or live algae, plants, or similar biological sources).
[0054] The bio-based BAGE compound of the present invention is bio-based, and substantially all carbon thereof is derived from natural or sustainable sources. That is, within experimental error, the bio-based BAGE compound of the present invention is determined to have a bio-based carbon content of 100% ± 1%. The bio-based BAGE compound of the present invention is substantially free of carbon from similarly non-sustainable and / or non-renewable resources. The bio-based BAGE compound of the present invention is substantially free of carbon derived from petroleum and / or petrochemicals, natural gas, or coal.
[0055] Similarly, the method for producing the bio-based BAGE compound of the present invention comprises using feedstocks and / or reagents containing carbon from renewable sources. As such, the process for producing the bio-based BAGE compound of the present invention utilizes starting materials that are substantially free of petroleum-based carbon. For example, the bio-based BAGE compound of the present invention may be produced from feedstocks obtained from sustainable agricultural activities, preferably using non-genetically modified organisms or biomass. Such feedstocks are referred to herein as "natural" and "renewable" (i.e., "sustainable") and are known in the art as non-petroleum-derived feedstocks. As a further example, the bio-based BAGE compound of the present invention may be produced from bio-based feedstocks derived from plant, vegetable, and / or algae sources and / or through fermentation. These exemplary materials for use to produce the bio-based BAGE compound of the present invention contain substantially only "new" carbon and are substantially free of "old" carbon fossil fuel sources. As such, the feedstocks and starting materials used to produce the bio-based BAGE compounds of the present invention are not derived from fossil sources such as petroleum, natural gas, and / or coal. Such products are referred to herein as "natural" products and are known in the art as non-petrochemical derived or "bio" products.
[0056] In this document, "sustainable" refers to materials derived from renewable resources. Conversely, "unsustainable" refers to materials from limited natural resources, such as fossil fuels (e.g., oil, natural gas, coal, etc.).
[0057] In some embodiments, the present invention relates to a bio-based BAGE compound of formula (I):
[0058]
[0059] In the formula, R1 is C6 to C 16 It is a branched alkyl, alkenyl, or alkynyl, and n is 1 to 3. Those skilled in the art will recognize that the bio-based BAGE compounds of the present invention, where n is 1, comprise glyceryl ethers. Similarly, the bio-based BAGE compounds of the present invention, where n is 2 or n is 3, comprise repeating glycerol functional groups and are polyglycerols themselves.
[0060] In some embodiments, the present invention comprises a substantially pure compound of formula (I) with one or more solvents or diluents. Also within the scope of the present invention are compositions comprising a mixture of bio-based BAGE compounds. In some embodiments, compositions comprising one or more compounds of formula (I) are C6 to C6, where n is 1 and R1 is various 16 It includes compounds that are combinations of branched alkyl, alkenyl, and alkynyl groups.
[0061] As used herein, R1 is branched C6 to C 16 It includes alkyl, alkenyl, and alkynyl groups. In some preferred embodiments, R1 is a branched C6 to C 16 It is an alkyl group.
[0062] In some embodiments, the ether bond to R1 occurs at a non-primary carbon atom, i.e., a secondary or tertiary carbon atom. Additionally, R1 is C6 to C 10 It may further comprise a branched alkyl, alkenyl, or alkynyl. In some embodiments, R1 is a C7 to C9 branched alkyl, alkenyl, or alkynyl. It is more preferable that R1 is a C7-C9 branched alkyl. In one specific embodiment, R1 is a branched C8 alkyl, alkenyl, or alkynyl. In one specific aspect of the invention, the compound of formula (I) is as follows:
[0063]
[0064] Other specific embodiments include a compound of formula (I) as shown below:
[0065]
[0066] The present invention also relates to compositions and formulations comprising the bio-based BAGE compounds of the present invention. In some embodiments, compositions and / or formulations comprising the bio-based BAGE compounds of the present invention are substantially free of any components prepared using non-sustainable carbon starting materials. However, without limitation, the bio-based BAGE compounds of the present invention are nevertheless compatible with components prepared using petroleum-based carbon.
[0067] In some embodiments, the bio-based BAGE compound of the present invention is present with a solvent and / or diluent. For example, one or more solvents or diluents may be added to control viscosity and / or facilitate the ease of handling for transport, storage, and / or subsequent use of the bio-based BAGE compound. The solvent and / or diluent may be combined with the bio-based BAGE compound of the present invention after synthesis or purification, or may be present through the retention of one or more solvent(s) and / or diluent(s) used during one or more synthesis and / or purification processes. In some embodiments, the composition comprises one or more bio-based BAGE compounds and a solvent and / or diluent present at a concentration of about 30% to about 90%, about 30% to about 80%, or about 30% to about 70% by weight of the composition.
[0068] In some embodiments, solvents and / or diluents for use with the compounds, compositions, formulations and / or processes of the present invention are bio-based (i.e., substantially free of non-renewable carbon). Solvents and / or diluents suitable for use with the compounds, compositions and / or processes of the present invention include, but are not limited to, water, glycerin, propanediol (e.g., 1,2-propanediol (propylene glycol), 1,3-propanediol, etc.), butanediol (e.g., 1,2-butanediol, 1,3-butanediol, 2,3-butanediol, etc.), and / or pentanediol (e.g., 1,2-pentanediol, 1,3-pentanediol, 2,3-pentanediol, etc.).
[0069] In some embodiments, the bio-based BAGE of Formula (I) of the present invention comprises R1 having one or more methyl branches (i.e., R1 is "methyl-branched type"), and the concentration of the methyl-branched bio-based BAGE is greater than about 95 weight%. In particular, the concentration of the methyl-branched bio-based BAGE in the composition is greater than about 95 weight%, and the total concentration of branched bio-based BAGE other than the methyl-branched compound is less than about 5 weight%. In certain embodiments, the concentration of the methyl-branched bio-based BAGE in the composition is greater than about 95 weight%, and the concentration of the ethyl-branched bio-based BAGE is less than about 5 weight%.
[0070] One specific embodiment comprises a composition comprising a compound of formula (I):
[0071]
[0072] and R1 is a methyl-branched C6 to C16 alkyl, alkenyl or alkynyl; n is 1 to 3, and at least one other component, the methyl branched compound is present in a ratio of 10:1 or greater relative to the concentration of the corresponding ethyl branched compound.
[0073] As used in this specification, the bio-based C6 to C of the present invention 16The "corresponding ethyl-branched compound" of the compound is one in which an ethyl group is present instead of a terminal methyl group, and is used only to describe an embodiment in which the terminal methyl group may be preferred. Such "relative" compounds may have the same number of carbon atoms in R1 or one more carbon atom.
[0074] In some embodiments, the methyl branched compound is present in the composition at a ratio of 12:1, 15:1, 20:1, 25:1, 50:1, or 100:1 relative to the concentration of the ethyl branched compound. In some embodiments, R1 is a methyl branched C6 to C having a single methyl branch. 16 It is an alkyl, alkenyl, or alkynyl compound and is present in the composition at a concentration of 95 weight% or more, 98 weight% or more, or 99 weight% or more.
[0075] In one specific embodiment, the bio-based compound in the composition is as follows:
[0076]
[0077] In some embodiments, the composition of the present invention comprises one or more of the following compounds, wherein the carbon in the compound is bio-based and preferably derived from a plant source:
[0078]
[0079] and / or
[0080]
[0081] The bio-based BAGE of the present invention may be incorporated into formulations for any product (or component of a product) comprising surfactants, cleansing agents, foam boosters, emulsifiers, skin conditioning agents, moisturizers, emollients, and / or deodorizers. Non-limiting examples of products that may contain the compound and / or composition include personal care, home care and / or institutional care products, pharmaceutical and / or veterinary products, food and / or food processing products, textile care products, products for industrial applications, etc. Products or components of products containing the bio-based BAGE compound and / or composition of the present invention include, but are not limited to, liquids, solids, aerosols, gels, waxes, oils, lotions, emulsions, oil-in-water emulsions, micelle compositions, etc. In some embodiments, the bio-based BAGE compound or a composition containing the bio-based BAGE compound is incorporated into a formulation for a personal care product or a component thereof. Non-limiting examples of personal care products that may include formulations include: cosmetics, conditioners for hair, nails, skin or fabrics, shampoos, hair styling products, oils or waxes for grooming facial hair, permanent wave liquids, hair dyes, face or body washes, makeup removers, cleansing lotions, emollient lotions or creams, bar soaps, liquid soaps, shaving creams, foams, or gels, sunscreens, gels, lotions or creams for treating sunburn, deodorants or antiperspirants, moisturizing gels, shaving foams, face powders, foundations, lipsticks, blushes, eyeliners, anti-wrinkle or anti-aging creams, eyeshadows, eyebrow pencils, mascaras, mouthwashes, toothpaste, oral care products, skin cleansing products, fabric cleansing products, wash products, hair or fur cleansing products, skin lotions or moisturizers, etc.
[0082] The embodiments include incorporation into a formulation together with at least one other component. In some embodiments, at least one other component is bio-based. Suitable formulations and additive components are described in the literature [ International Cosmetic Ingredient Dictionary and Handbook [, 16th Edition published by the Personal Care Products Council, Washington, DC] and Personal Care Products Council On-Line INFOBASE (http: / / online.personalcarecouncil.org) include, but are not limited to, what is known to those skilled in the art.
[0083] The formulations and ingredients may include, but are not limited to, the following: water, surfactants, emollients, moisturizers, conditioning agents for hair, skin or nails, chelating agents, activators, bleaching or whitening agents, additional pH adjusters, fragrances, colorants, exfoliants, antioxidants, plant components, e.g., plant extracts, mica, smectite, thickeners, cannabinoids, oils, dyes, waxes, amino acids, nucleic acids, vitamins, hydrolyzed proteins and their derivatives, glycerin and its derivatives, enzymes, anti-inflammatory and other agents, biocides, antifungals, preservatives, antioxidants, UV absorbers, dyes and pigments, preservatives, UV blocking agents, antiperspirant agents, oxidizing agents, pH balancing agents, moisturizers, peptides and their derivatives, anti-aging agents, hair growth promoters, anti-cellulite agents, and those acceptable for use in formulations for human use.
[0084] The formulation and composition may comprise one or more bio-based BAGE compounds. In a preferred embodiment, the type and amount of the bio-based BAGE compound used in the embodiment of the formulation and / or composition impart an antimicrobial or preservative effect to the formulation and / or composition to preserve the formulation and / or composition against microbial contamination and / or to improve antimicrobial efficacy against surfaces, e.g., skin, hair, etc. Accordingly, one embodiment comprises a formulation and / or composition comprising at least one whole bio-based branched intermediate-chain-terminal diol and at least one other component. Further aspects of the present invention encompass a method for attenuating microbial contamination, comprising blending an effective amount of at least one whole bio-based branched intermediate-chain-terminal diol with at least one other component. An embodiment of the formulation(s) and / or composition(s) comprises a bio-based branched intermediate-chain-terminal diol which is a bio-based BAGE compound of Formula (I):
[0085]
[0086] In the formula, R1 is C6 to C 16 It is a branched alkyl, alkenyl, or alkynyl, and n is 1 to 3. In some embodiments, R1 is C6 to C 10 am.
[0087] In one specific embodiment, the branched intermediate chain terminal diol is as follows:
[0088]
[0089] In another specific embodiment, the branched intermediate chain-terminal diol is the compound shown below:
[0090]
[0091]
[0092] An effective amount of the bio-based BAGE compound in the formulation comprises about 0.05 wt% to about 10 wt%, preferably about 0.1 wt% to about 5 wt%, and more preferably about 0.25 wt% to about 4 wt%. In a specific embodiment, the bio-based BAGE compound is bio-based methylheptylglycerin (“bio-MHG”), wherein the formulation and / or composition comprises about 0.05 wt% to about 10 wt% of bio-MHG, preferably 0.2 wt% to about 5 wt% of bio-MHG, most preferably about 0.5 wt% to about 2.5 wt% of MHG.
[0093] Formulations and / or compositions and methods for preserving and attenuating microbial contamination may have a pH value of about 2 to about 10, preferably about 3 to about 9, most preferably about 4 to about 8. Certain embodiments will have a pH of less than about 7, preferably less than about 6.5, more preferably less than about 6, most preferably less than about 5.6.
[0094] In another embodiment, the antimicrobial and / or preservative efficacy of the bio-based BAGE compound of the present invention may be enhanced through the use of a booster, i.e., a compound known to those skilled in the art for enhancing bacteriostatic and / or fungistatic activity. The intermediate chain (i.e., C4 to C4) 10 ) Diols, medium-chain polyols, and chelating agents may be added to the composition as boosters, all of which are preferably bio-based. Blends of bio-based BAGE compounds with these boosters may be prepared as concentrates for addition to formulations to prevent microbial contamination and growth. Suitable medium-chain diols include, but are not limited to, alkanediols and glyceryl esters. Suitable C4 to C 10Alkanediols include, but are not limited to, 1,2-alkanediols, 2,3-alkanediols, and mixtures thereof, such as 1,2-butanediol, 1,2-hexanediol, 1,2-heptanediol, caprylyl glycol, decylene glycol, 2,3-butanediol, 2,3-octanediol, etc., and are preferably bio-based. Suitable glyceryl esters are typically one or more C6 to C 10 It is a monoester of glycerol having a fatty acid; examples of such glyceryl esters include glyceryl caproate, glyceryl heptanoate, glyceryl caprylate, glyceryl pelargonate, glyceryl caprate, and glyceryl caprylate / caprate. Bio-based polyols that may be added to such compositions include glycerin, propanediol (e.g., 1,2-propanediol (propylene glycol), 1,3-propanediol, etc.), butanediol (e.g., 1,2-butanediol, 1,3-butanediol, 2,3-butanediol, etc.), pentanediol (e.g., 1,2-pentanediol, 1,3-pentanediol, 2,3-pentanediol, etc.), sorbitol, sorbitan, etc. Bio-based chelating agents are bio-based C6-C 10 Alkylhydroxamic acids and their corresponding alkylhydroxamate salts, such as heptanohydroxamic acid, caprylohydroxamic acid (caprylhydroxamic acid), pelargohydroxamic acid, and caprohydroxamic acid, are included. Preferably, caprylohydroxamic acid (caprylhydroxamic acid) or its corresponding hydroxamate salt, such as potassium caprylohydroxamate or sodium caprylohydroxamate. Other bio-based chelating agents that can be used as boosters include tetrasodium glutamate diacetate, phytic acid and its salts, gluconic acid and its salts, galacturonic acid and its salts, galactaric acid and its salts, and combinations thereof.
[0095] In some embodiments, the bio-based BAGE compound of the present invention is present in the composition of a preservative blend by preparing a mixture of the bio-based BAGE compound and one or more of the aforementioned components. Such a preservative blend composition containing the bio-based BAGE compound of the present invention has additional utility in the formulation(s) of end consumer products. In some embodiments, the preservative blend is a homogeneous mixture or solution of the bio-based BAGE compound and other components. One preferred embodiment of such a preservative blend comprises one or more bio-based BAGE compounds and an alkylhydroxysanic acid or its corresponding alkylhydroxysamate salt, and, optionally, a diol or a polyol. In such embodiments, the bio-based BAGE compound is present at a concentration of about 20% to about 80%, preferably about 30% to about 80%, and more preferably about 50% to about 75%. In such embodiments, the alkylhydroxy acid is present at a concentration of about 1% to about 20%, preferably about 2% to about 15%, and more preferably about 4% to about 15%. In these embodiments, the diol or polyol is optionally present at a concentration of about 5% to about 70%, preferably about 10% to about 60%. In one exemplary embodiment, the present invention relates to a preservative blend comprising 60% to 80% methylheptylglycerin (MHG), 10% to 20% caprylhydroxy acid (CHA), and 10% to 20% glycerin, propanediol, or a combination thereof. In a particularly preferred embodiment, the present invention relates to a preservative blend comprising about 65% to about 75% methylheptylglycerin, about 12.5% to about 17.5% caprylhydroxamic acid, and about 12.5% to about 17.5% glycerin, propanediol, or a combination thereof. In some embodiments, MHG, CHA, and glycerin or propanediol are each bio-based.
[0096] Embodiments of formulations and / or compositions and methods for preserving and attenuating microbial contamination may further comprise reducing microorganisms by 90% within one week to one month. Certain embodiments comprise reducing microorganisms by 90% within seven days. Other embodiments comprise reducing bacteria by 99% and yeast and fungi by 90% within seven days.
[0097] Embodiments of formulations and / or compositions may incorporate and take the following forms, for example without limitation: solutions; conditioners for hair, nails, skin, or fabrics; shampoos; hair sprays; mustache / beard oils or waxes; hair styling agents; permanent wave liquids; hair dyes; glazes; skin lotions; face and body washes; makeup removers; cleansing lotions; emollient lotions / creams; bar soaps; shaving creams; sunscreens; sunburn treatments; deodorants; moisturizing gels; moisturizing essences; UV protection essences; shaving foams; face powders; foundations; lipsticks, blushes; eyeliners; anti-wrinkle and anti-aging creams; eyeshadows; eyebrow pencils; mascaras; mouthwashes; toothpaste; oral care compositions; skin cleansing compositions; fabric cleansing compositions; dishwashing compositions; hair or fur cleansing compositions; deodorants or antiperspirants; color cosmetics or makeup; hair styling compositions; Skin moisturizer; skin conditioner; hair conditioner and nail conditioner.
[0098] In some embodiments, the formulations of the present invention have a reduced "soaping" or foaming effect when applied to the skin compared to compositions lacking the compounds of the present invention. Generally, foaming may occur while applying to the skin, hair, or other surfaces. While the foaming effect may be beneficial in some applications, such as shower gels or shampoos, foaming may not be desirable in formulations of creams, lotions, and aqueous solutions intended for use on skin, hair, and other surfaces, for example.
[0099] For example, in some formulations, such as personal care products, excipients such as silicone are commonly added to reduce the foaming behavior of the formulation when applied to skin, hair, or other surfaces. However, silicone is generally undesirable for use in personal and / or home care and its applications, and its use is the subject of significant controversy. In some formulations, silicone is used as a cost-effective alternative to high-quality vegetable oils. However, silicone is well known to not decompose easily and persist in the natural environment, potentially causing adverse effects on fauna and / or flora. Accordingly, in some embodiments, compositions and formulations containing the bio-based BAGE compounds of the present invention are "silicone-free" (i.e., free of silicones such as dimethicone, cyclopentasiloxane, etc.). "Silicone-free" compositions and formulations contain less than 1% by weight, preferably less than 0.5% by weight, more preferably less than 0.1% by weight of silicone components, or most preferably not contain silicone at a measurable concentration or amount. Typically, silicone-free compositions respond to friction (e.g., rubbing of the skin) by becoming increasingly opaque or “soaping,” resulting in an undesirable whitening effect. This effect is particularly common in silicone-free formulations that are oil-in-water emulsions. Silicone is generally added to provide “anti-soaping” benefits. In some embodiments, formulations containing the bio-based BAGE compounds of the present invention exhibit a reduced or substantially reduced soaping effect—that is, they may be referred to as “non-soaping” compositions or formulations. Accordingly, some embodiments include silicone-free non-soaping formulations containing at least one bio-based BAGE compound of the present invention. In some embodiments, the silicone-free non-soaping formulation contains the bio-based BAGE compound of the present invention at a concentration of about 0.05 wt% to about 10 wt%, preferably about 0.5 wt% to about 2.5 wt%.
[0100] In some embodiments, compositions and formulations containing the bio-based BAGE compound of the present invention are silicone-free oil-in-water emulsions comprising an aqueous phase and a non-aqueous, water-insoluble oil phase. In some embodiments, the oil-in-water emulsion comprises an emulsifier or a stabilizer. Solvents, emollients, and other components suitable for use in the oil phase of the emulsion generally comprise hydrocarbons, esters, triglycerides, etc. Suitable emulsifiers include known anionic, cationic, nonionic, or zwitterionic emulsifiers. One or more nonionic fatty alcohols may be present as covalent agents. Compositions and formulations containing the bio-based BAGE compound of the present invention may also comprise a micelle solution comprising water and at least one surfactant.
[0101] The present invention also relates to a process for manufacturing bio-based BAGE compounds. For example, a process for manufacturing a compound of formula (I):
[0102]
[0103] In the formula, R1 is C6 to C 16 It is an alkyl branched, alkenyl, or alkynyl type; n is 1 to 3, and the method is a bio-based branched C6 to C in the presence of a catalyst. 16 It includes contacting an alcohol, alkenol, or alkinol with a bio-based C3 epihalohydrin or oxiranyl alcohol and then hydrolyzing it.
[0104] An example of a bio-based epihalohydrin includes epichlorohydrin (“bio-ECH”). Bio-ECH can be obtained from any process that converts vegetable glycerin into ECH. Vegetable glycerin refers to glycerol produced by the hydrolysis or transesterification (e.g., methanelysis) of vegetable triglycerides, e.g., palm oil, coconut kernel oil, soybean oil, rapeseed oil, canola oil, cottonseed oil, castor oil, sunflower seed oil, etc. Vegetable glycerin is preferably derived by directly hydrolyzing vegetable triglyceride oil with steam under high temperature and high pressure to break down the oil into glycerin and fatty acids. The glycerin can then be converted into bio-ECH, for example, as shown in Reaction Scheme 4.
[0105] Reaction Equation 4
[0106] Therefore, one embodiment is a bio-based C4 to C 10 This includes the reaction of branched alcohols with bio-ECH. Bio-based oxiranyl alcohols, such as bio-glycidol, can also be used to obtain a glyceryl ether moiety. Exemplary catalysts such as boron trifluoride or tin tetrachloride can be used.
[0107] In a preferred embodiment, bio-based C6 to C 16 Branched alcohols react with bio-ECH via a co-etherification-hydrolysis pathway to produce 100% bio-based bags that offer equal or improved performance, enhanced sustainability, and better consumer perception compared to petrochemical-derived bags. For example, the reaction of bio-2-octanol with bio-ECH yields bio-methylheptylglycerin (bio-MHG) as shown in Reaction Scheme 5 below.
[0108] Reaction Equation 5
[0109] In a specific embodiment, bio-based C6 to C 16 Branched alkyl, alkenyl, alkynyl, or any combination thereof comprises an alcohol having a methyl branch and may have only a single branch point on the carbon backbone. The branch point may be defined for any carbon or heteroatom within the molecule or may also refer to a stereocenter. For example, in a specific embodiment, the methyl branch is located at the 1-position—that is, the methyl branch is located on the carbon atom having the hydroxyl group of the alcohol (e.g., 1-methylheptyl alcohol) as shown below:
[0110]
[0111] In certain embodiments, the bio-based branched alcohol is a secondary alcohol. Some exemplary bio-based branched alcohols are C6 to C 10 Includes branched alcohols. In some embodiments, preferred bio-based C6 to C 10 Branched alcohol is entirely bio-based 2-octanol ("1-methylheptyl alcohol").
[0112] Those skilled in the art understand that bio-based BAGE can be synthesized through any route capable of efficiently converting bio-based precursors into BAGE. For example, various routes available for the synthesis and purification of BAGE exist, including US6437196B1 and references cited herein, US7666903B2 and references cited herein, and US8877983B2 and references cited herein, all of which are incorporated herein in their entirety. Homogeneous or heterogeneous acid or base catalysis may be used. A typical reaction route based on bio-ECH will produce glycidyl ether as an intermediate, which can be hydrolyzed in situ to the corresponding glyceryl ether using an aqueous base. Suitable bases include sodium hydroxide, potassium hydroxide, calcium hydroxide, etc. The reaction may be carried out in bulk or in a solvent, but a bulk reaction is preferred to avoid the need for solvent recovery, recycling, or disposal.
[0113] The generated BAGE may be purified by any means known to the art, including distillation, liquid-liquid separation, liquid-phase extraction, solid-phase extraction, chromatographic separation, filtration, etc. Such processes may be used to remove any unreacted starting materials and undesirable by-products, odors, or colors from the BAGE product.
[0114] Examples
[0115] These detailed descriptions serve to illustrate the general descriptions and embodiments that form part of the present invention. These detailed descriptions are provided for illustrative purposes only and are not intended to limit the scope of the present invention.
[0116] Example 1: Bio-based methylheptylglycerin ("Bio-MHG")
[0117] Bio-MHG was prepared according to methods known in the art for the synthesis of petrochemical-based BAGEs summarized as follows: Bio-2-octanol (Oleris) in the presence of a Lewis acid catalyst (SnCl4). ® 2-Octanol, 99%, Arkema, Inc.) bio-epichlorohydrin (i.e., "ECH") (Epicerol ® A glycidyl ether intermediate was formed by reacting with (Advanced Biochemical Thailand Co., Ltd.), and this was immediately hydrolyzed in situ by reacting with aqueous sodium hydroxide. After pH adjustment and separation, the resulting crude bio-MHG was esterified with formic acid, and the formic acid ester adduct was purified by distillation. Subsequently, the ester was hydrolyzed, separated, distilled, and deodorized to obtain bio-MHG with a purity of 99+%.
[0118] ASTM Method D6866-18 Radiocarbon ( 14 C) Characterization of bio-MHG according to the determination is 14 It was indicated that C was present at 100% ± 1%. Therefore, substantially all carbon present in Bio-MHG was bio-based, and there was substantially no petrochemical carbon in the Bio-MHG composition.
[0119] Example 2: Natural lotion formulation containing bio-MHG
[0120] A lotion containing 100% bio-based ingredients was prepared according to the formulations in Table 1 using the following procedure: Water and glycerin were filled into a beaker of appropriate size equipped with an overhead mechanical stirrer, an anchor-type blade, and a heating hot plate. Mixing was started at low-to-medium speed, and xanthan gum was slowly sieved into the aqueous phase and mixed until uniformly dispersed (no lumps remained). The mixture was then heated to 80°C. The oil phase ingredients were combined in a separate beaker, heated to 80°C while mixing at low speed, and mixed until homogeneous. The oil phase mixture was added to the aqueous phase mixture at 80°C while mixing at medium-to-high speed. Once a uniform appearance was reached, the mixture was allowed to cool to approximately 75°C and then homogenized at 3500 rpm for 3 minutes. After homogenization, the mixture was allowed to cool to approximately 45–50°C while stirring at medium speed. Methylheptylglycerin was added at 45–50°C. When cooling to ambient temperature (23℃ ± 2℃), the batch pH was adjusted to 5.1 ± 0.1 using citric acid (20% aqueous solution). The composition was mixed until homogeneous, and then discharged into a suitable container for storage.
[0121]
[0122] Example 3: Natural lotion formulation containing bio-MHG
[0123] Example 3 was prepared according to the procedure used in Example 2, and the percentage of methylheptylglycerin added to the formulation was only 1.00%.
[0124] Comparative Example 1: Natural lotion formulation without bio-MHG
[0125] Comparative Example 1 was prepared according to the procedure used in Example 2, and only methylheptylglycerin was omitted from the chemical formula.
[0126] Microbial Challenge Test (MCT) of Natural Lotion Formulations to Determine Preservative Efficacy:
[0127] To determine the preservative efficacy of Bio-MHG of Example 1, a challenge test was performed in compliance with the United States Pharmacopoeia (USP) and PCPC pharmacopoeia test methods. (Refer to literature published by the Personal Care Products Council of Washington, D.C. [Personal Care Products Council Technical Guidelines, Microbiology Guidelines, 2018 Edition] and references cited herein). The results are shown in Tables 2A through 2D. The tables represent the log values of the number of viable organisms measured after the expiration time interval. The row titled "Inoculum Level" represents the initial number of organisms present at the start of the test.
[0128] Comparative Example 1, which does not contain Bio-MHG, does not meet the PCPC acceptance criteria of a 99% reduction in bacteria and a 90% reduction in yeast and fungi within 7 days. Examples 2 and 3, which contain Bio-MHG as a preservative to inhibit microbial growth, meet both USP 51 and PCPC acceptance criteria for all organisms and exceed acceptance criteria for Gram-positive bacteria, Gram-negative bacteria, and yeast. Examples 2 and 3 were also observed to meet the European Pharmacopeia (EP) "B" criteria (EP-B) for the control of bacteria, yeast, and fungi, namely a 99.9% reduction in bacteria (3-log reduction) within 14 days and a 90% reduction in yeast and fungi (1-log reduction) within 14 days (see [European Pharmacopeia (Ph. Eur.) 10.0, 2021, Section 5.1.3, Efficacy of Antimicrobial Preservation]).
[0129]
[0130]
[0131]
[0132]
[0133] Example 4: Natural lotion formulation containing bio-MHG
[0134] Example 4 was prepared according to the procedure used in Example 2, but only the pH of the formulation was adjusted to a pH value of 6.5 ± 0.2.
[0135] Example 5: Natural lotion formulation containing bio-MHG
[0136] Example 5 was prepared according to the procedure used in Example 4, and the percentage of methylheptylglycerin added to the formulation was only 1.00%.
[0137] Comparative Example 2: Natural lotion formulation without bio-MHG
[0138] Comparative Example 2 was prepared according to the procedure used in Example 4, with only methylheptylglycerin omitted from the chemical formula.
[0139] Microbial Challenge Test (MCT) of Natural Lotion Formulations to Determine Preservative Efficacy:
[0140] To determine the preservative efficacy of Bio-MHG of Example 1, a challenge test was performed in compliance with the USP and PCPC pharmacopoeial test methods. The results are shown in Tables 4A-4D. The tables represent the log values of the number of viable organisms measured after the expiration time interval. The row titled "Inoculum Level" indicates the initial number of organisms present at the start of the test.
[0141] Comparative Example 2, which does not contain Bio-MHG, does not meet the PCPC acceptance criteria of a 99% reduction in bacteria and a 90% reduction in yeast and fungi within 7 days. Examples 4 and 5, which contain Bio-MHG as a preservative to inhibit microbial growth, meet all PCPC acceptance criteria for all organisms and exceed the acceptance criteria for Gram-positive bacteria, Gram-negative bacteria, and yeast. Examples 4 and 5 were also observed to meet the European Pharmacopeia (EP) "A" criteria for the control of bacteria, yeast, and fungi, i.e., EP-A (see reference [European Pharmacopeia (Ph. Eur.) 10.0, 2021, Section 5.1.3, Efficacy of Antimicrobial Preservation]).
[0142]
[0143]
[0144]
[0145] Examples 6: Bio- MHG including Mycella Water Formulation
[0146] Mycellar water was prepared according to the formulations in Table 5 using the following procedure: Water was filled into a beaker of appropriate size equipped with an overhead mechanical stirrer and an anchor-type blade. Mixing was started at a low-to-medium speed, polysorbate 20, butylene glycol, and methylheptylglycerin were added to the batch, and the mixture was stirred until a clear and homogeneous solution was formed. Citric acid (20% aqueous solution) was added to adjust the pH to 5.1 ± 0.1. The batch was mixed until homogeneous, and then discharged into a suitable container for storage.
[0147]
[0148] Examples 7: Bio- MHG including Mycella Water Formulation
[0149] Example 7 was prepared according to the procedure used in Example 4, but only the pH of the formulation was adjusted to 6.5 ± 0.2.
[0150] Comparative Example 3: Mycellar water formulation without bio-MHG
[0151] Comparative Example 3 was prepared according to the procedure used in Example 4, with only methylheptylglycerin omitted from the chemical formula.
[0152] Comparative Example 4: Mycellar water formulation without bio-MHG
[0153] Comparative Example 4 was prepared according to the procedure used in Example 7, with only methylheptylglycerin omitted from the chemical formula.
[0154]
[0155]
[0156]
[0157]
[0158] Microbiological challenge test ("MCT") of a mycella water formulation to determine preservative efficacy:
[0159] To determine the preservative efficacy of Bio-MHG in Example 1, a challenge test was performed in compliance with the USP and PCPC pharmacopoeia test methods. The results are shown in Tables 6A-D. "N / R" indicates "not reported".
[0160] Comparative Examples 3 and 4, which do not contain Bio-MHG, do not meet the PCPC acceptance criteria of a 99% reduction in bacteria and a 90% reduction in yeast and fungi within 7 days. Examples 6 and 7, which contain Bio-MHG as a preservative to inhibit microbial growth, demonstrate significant preservative efficacy. Example 6 meets or exceeds all PCPC acceptance criteria for all organisms and also meets the EP-A acceptance criteria of a 99% reduction in bacteria within 2 days (2-log reduction), a 99.9% reduction in bacteria within 7 days (3-log reduction), and a 99% reduction in yeast and fungi within 7 days (2-log reduction). Example 7, exhibiting a higher pH value, demonstrates a significant improvement in preservative efficacy against Gram-positive bacteria, Gram-negative bacteria, and yeast compared to the unpreserved control (Comparative Example 4); however, mycella water preserved with Bio-MHG at pH 6.5 ± 0.2 did not meet the PCPC acceptance criteria for preservative efficacy against fungi.
[0161]
[0162] Examples 8: Bio- MHG UV protection formulation containing
[0163] A sunscreen formulation containing Bio-MHG was prepared according to the formulations in Table 7 following the procedure below: Xanthan gum was dispersed in glycerin to form a premix. Water, the glycerin-xanthan gum premix, butylene glycol, tetrasodium EDTA, and methylheptylglycerin were added to a beaker of appropriate size equipped with an overhead mechanical stirrer and a hot plate. This aqueous phase was heated to 80°C and mixed until homogeneous. The oil phase components were combined in a separate beaker, heated to 80°C, and mixed until homogeneous. When both phases were at 80°C and homogeneous, the oil phase was added to the aqueous phase while mixing at medium to high speed to form an emulsion. The emulsion was homogenized at 3500 rpm for 3 minutes. During mixing, the batch was cooled to 45°C, and during the cooling period, Simulgel NS and silica were added to the formulation and mixed until homogeneous. When cooling to ambient temperature (23℃ ± 2℃), the batch pH was adjusted to 5.1 ± 0.1 using citric acid (20% aqueous solution). The batch was mixed until homogeneous, then discharged into a suitable container for storage.
[0164] Example 9: Sunscreen formulation containing bio-MHG
[0165] Example 9 was prepared according to the procedure of Example 8, but the concentration of Bio-MHG in the formulation was increased to 1.50%.
[0166] Comparative Example 5: Sunscreen formulation without bio-MHG
[0167] Comparative Example 5 was prepared according to the formulation of Table 7 using the procedure of Example 8, but with only Bio-MHG omitted from the formulation.
[0168] Example 10: Sunscreen formulation containing bio-MHG
[0169] Example 10 was prepared according to the formulation of Table 8 using the procedure of Example 8, but the pH of the formulation was adjusted to 6.5 ± 0.2 using citric acid (20% aqueous solution).
[0170] Example 11: Sunscreen formulation containing bio-MHG
[0171] Example 11 was prepared according to the formulation of Table 8 using the procedure of Example 10, but the concentration of bio-MHG in the formulation was increased to 1.50%.
[0172] Comparative Example 6: Sunscreen formulation without bio-MHG
[0173] Comparative Example 6 was prepared according to the formulation of Table 8 using the procedure of Example 10, but with only Bio-MHG omitted from the formulation.
[0174]
[0175] To determine the preservative efficacy of Bio-MHG of Example 1 in sunscreen formulations, a challenge test was performed in compliance with the USP and PCPC pharmacopoeia test methods. The results are shown in Tables 9A-F.
[0176]
[0177]
[0178]
[0179]
[0180]
[0181]
[0182] Comparative Examples 5 and 6, which do not contain Bio-MHG, do not meet the PCPC acceptance criteria of a 99% reduction in bacteria and a 90% reduction in yeast and fungi within 7 days. Examples 8 to 11, which contain Bio-MHG as a preservative to inhibit microbial growth, demonstrate substantial preservative efficacy that meets or exceeds all USP, PCPC, and EP (A and B) acceptance criteria for all organisms.
[0183]
[0184] Example 12: Natural shampoo formulation containing bio-MHG
[0185] Example 12 was prepared according to the formulation of Table 10. Water, lauryl glucoside, sodium cocoyl glutamate, cocamidopropyl betaine, and methylheptylglycerin were filled into a beaker of appropriate size equipped with an overhead mechanical stirrer. After mixing the batch at low to medium speed until the contents became homogeneous, the pH was adjusted to 5.1 ± 0.1 using citric acid (20% aqueous solution).
[0186] Example 13: Natural shampoo formulation containing bio-MHG
[0187] Example 13 was prepared according to the formulation of Table 10 using the procedure of Example 12, but the concentration of bio-MHG in the formulation was increased to 1.50%.
[0188] Comparative Example 7: Natural shampoo formulation without bio-MHG
[0189] Comparative Example 7 was prepared according to the formulation of Table 10 using the procedure of Example 10, but with only Bio-MHG omitted from the formulation.
[0190] To determine the preservative efficacy of Bio-MHG of Example 1 in natural shampoo formulations, a challenge test was performed in compliance with the USP and PCPC pharmacopoeia test methods. The results are shown in 11A-C.
[0191]
[0192]
[0193]
[0194] Examples 12 and 13 contained Bio-MHG as a preservative to inhibit microbial growth and demonstrated significant preservative efficacy that met or exceeded the USP, PCPC, and EP-B acceptance standards for all organisms, whereas Comparative Example 7 was proven to have significantly weak preservative efficacy.
[0195] Examples 14-17: Lotion formulation containing a bio-MHG preservative blend
[0196] Bio-MHG Spectrastat TMPreservative ingredient blends were prepared in combination with CHA (caprylhydroxamic acid or CHA) and glycerin or propanediol. Preservative blend A was a homogeneous mixture consisting of 71% bio-MHG, 15% CHA, and 14% glycerin; in preservative blend B, bio-based 1,3-propanediol was replaced with glycerin. Natural lotion formulations similar to those of Examples 4 and 5 were prepared according to the formulations in Table 12 using previously indicated procedures. Preservative blends A and B were included instead of bio-MHG. Comparative Example 2, which did not contain bio-MHG or preservative blends, was evaluated for comparison.
[0197]
[0198] The efficacy of preservative blends A and B in natural lotion formulations was determined by performing challenge tests in compliance with USP and PCPC pharmacopoeial test methodologies. The results are shown in Tables 12A-E.
[0199]
[0200]
[0201]
[0202]
[0203]
[0204]
[0205] Examples 14 to 17 containing bio-MHG-based preservative blends demonstrated significant preservative efficacy that met or exceeded the acceptance criteria of USP, PCPC, EP-A, and EP-B for all organisms, whereas Comparative Example 2 demonstrated very poor preservative efficacy and failed to meet the acceptance criteria for bacteria and yeast. Compared to the natural lotion formulations of Examples 4 and 5 using bio-MHG alone at 1.0 wt% and 1.5 wt%, respectively, greater preservative efficacy is observed at lower concentrations of bio-MHG (0.71 wt%) when used as an ingredient in preservative blends A and B. This result is attributed to the boosting effect of CHA, which enhances the efficacy of bio-MHG.
[0206] Example 18 and Comparative Examples 8-10: Anti-soaping action of Bio-MHG
[0207] Preparation of a cationic oil-in-water ("O / W") emulsion. The cationic O / W emulsion of Table 13 was prepared according to the following procedure: The aqueous component was filled into a beaker of appropriate size equipped with an overhead mechanical stirrer and a hot plate and heated to 80°C while mixing until homogeneous. The oil phase component was filled into a separate beaker and heated to 80°C while mixing until homogeneous. When both phases were at 80°C and homogeneous, the oil phase was added to the aqueous phase and homogenized at 4000 rpm for 3 minutes. The resulting emulsion was cooled to ambient temperature while mixing gently at low speed, and then discharged into a suitable container for storage. The resulting emulsion had a pH value in the range of 4.0 to 4.2.
[0208] Table 13. Cationic O / W emulsions of Example 18 and Comparative Examples 8 to 10.
[0209]
[0210] Soaping evaluation upon application: A controlled amount of emulsion was applied to the clean, dry forearms of the subjects. The emulsion was rubbed into the skin in a controlled manner, and the appearance of the emulsion on the skin was evaluated as a function of the number of rubs. "Rubbing" is defined as a single back-and-forth sweep of the index and middle fingers of the dominant hand to spread the emulsion on the forearm using consistent movement and constant pressure. Images of the emulsion on the skin were captured after 4, 8, and 12 rubs. Panelists (n = 18) were asked to evaluate the appearance of the soaping effect in the images on a scale of 0 to 5 (5 being the maximum soaping appearance). The scores were normalized for Comparative Example 9 (silicone-free control group), defined as having a soaping score of 5 after 4, 8, and 12 rubs. The evaluation results are shown in Table 14 and Figure 1.
[0211] Table 14. Soaping evaluation results for cationic O / W emulsions
[0212]
[0213] Comparative Example 8, a cationic O / W emulsion containing 5% dimethicone, does not exhibit a soaping effect when applied and rubbed onto the skin, and is evaluated to have an average soaping score of essentially 0 as a function of the number of rubs. The dimethicone of Comparative Example 8 is a silicone substitute triglyceride, triheptanoin, and hydrocarbon, C 13-15 (LexFeel), a mixture of alkanes and softeners ®When replaced with WOW-A, the resulting silicon-free O / W emulsion exhibits severe soaping upon rubbing. Comparative Example 9 demonstrates a traditional approach to mitigating this effect using a small amount of silicon (0.5 wt% dimethicone) and additional caprylyl glycol. Example 18 achieves a similar silicon-free O / W emulsion by incorporating 2.0 wt% bio-MHG instead of the 0.5 wt% dimethicone and 2.0 wt% caprylyl glycol of Comparative Example 10, although the anti-sowing performance is not slightly improved by using bio-based MHG instead of petroleum-based components.
[0214] Example 19: Anti-sowing effect of Bio-MHG in anionic / nonionic O / W emulsions
[0215] Oil-in-water ("O / W") emulsions stabilized by glyceryl stearate SE (a self-emulsifying combination of the nonionic emulsifier glyceryl stearate and the anionic emulsifier potassium stearate) and cetyl and stearyl alcohols were prepared according to the formulations described in Table 15 using a procedure similar to that of Examples 4 and 5. A comparative O / W emulsion was prepared as Comparative Example 11, in which bio-MHG was omitted from the formulation. Formulation details are provided in Table 15.
[0216] Table 15. Anionic / nonionic O / W emulsions of Example 19 and Comparative Example 11.
[0217]
[0218] When evaluating the soaping behavior upon rubbing, Comparative Example 11 was observed to exhibit severe soaping and a whitening appearance, whereas the O / W emulsion of Example 19 containing bio-MHG upon rubbing exhibited a dramatic reduction in soaping behavior and a desirable aesthetic.
[0219] * * *
[0220] The scope of the present invention is not limited by the specific embodiments described herein. In fact, various modifications of the present disclosure other than those described will be apparent to those skilled in the art from the foregoing description and the accompanying drawings. Such modifications are intended to fall within the scope of the appended claims.
[0221] It should also be understood that all values are approximations and are provided for illustrative purposes. All references cited and discussed in this specification are incorporated herein by reference in their entirety to the same extent that each reference is incorporated individually.
[0222] References
[0223]
[0224] Also refer to U.S. Patents No. 6,437,196 B1; No. 7,666,903 B2; and No. 8,877,983.
Claims
Claim 1 Bio-based compound of chemical formula (I): Among the formulas, the compound of the above formula (I) is a compound of at least 99% purity 3-[(1-methylheptyl)oxy]-1,2-propanediol. Claim 2 delete Claim 3 delete Claim 4 An antimicrobial composition comprising a bio-based compound of formula (I) according to claim 1. Claim 5 delete Claim 6 delete Claim 7 delete Claim 8 An antimicrobial composition according to claim 4, comprising a compound of formula (I) at a concentration of 20% to 80% by weight and an alkylhydroxamic acid or its alkylhydroxamate salt at a concentration of 1% to 20% by weight. Claim 9 delete Claim 10 A process for manufacturing a bio-based compound of formula (I) according to claim 1, wherein the process comprises contacting bio-based 2-octanol with bio-based epichlorohydrin in the presence of a catalyst and then hydrolyzing it. Claim 11 delete Claim 12 In paragraph 10, the catalyst is boron trifluoride or tin tetrachloride, in the process. Claim 13 delete Claim 14 delete Claim 15 A formulation comprising a bio-based compound of formula (I) according to claim 1 and at least one other component. Claim 16 In claim 1, the bio-based compound is a bio-based compound that is liquid at room temperature. Claim 17 In claim 15, the formulation is a personal care product, home care product, textile care product, organ care product, pharmaceutical product, veterinary product, food product, or product for industrial application or is a component thereof, and the at least one other component is water, surfactant, emollient, humectant, conditioning agent, chelating agent, activator, bleaching or whitening agent, pH adjuster, fragrance, emulsifier, exfoliant, antioxidant, plant component, mica, smectite, thickener, cannabinoid, oil, wax, amino acid, nucleic acid, vitamin, hydrolyzed protein and derivative thereof, glycerin and derivative thereof, enzyme, anti-inflammatory and other agent, biocide, antifungal agent, preservative, antioxidant, UV absorber, dye and pigment, preservative, UV blocking agent activator, antiperspirant activator, oxidizing agent, pH balancing agent, humectant, peptide and derivative thereof, anti-aging agent, hair growth promoter, A formulation selected from the group consisting of anti-cellulite active agents and combinations thereof. Claim 18 In claim 15, the bio-based compound of the above formula (I) is present in a concentration of 0.05% to 10% by weight based on the total weight of the formulation. Claim 19 In item 15, the above formulation is a silicone-free formulation. Claim 20 In item 15, the above formulation is a lotion, mycellar water, oil-in-water emulsion, sunscreen, shampoo, or deodorant. Claim 21 In claim 15, the above formulation is a liquid, solid, aerosol, gel, wax, oil, emulsion, or micelle composition. Claim 22 An antimicrobial composition according to claim 4, further comprising a booster selected from the group consisting of intermediate chain diols, polyols, chelating agents, and combinations thereof. Claim 23 In paragraph 22, the above intermediate chain diol is C4 to C 10 Alkanediol, C6 to C 10 The polyol is selected from the group consisting of glyceryl esters having fatty acids and combinations thereof, the polyol is selected from the group consisting of glycerin, 1,2-propanediol, 1,3-propanediol and combinations thereof, and the chelating agent is C6 to C 10 An antimicrobial composition selected from the group consisting of alkylhydroxysanic acid or its alkylhydroxysamate salt, tetrasodium glutamate diacetate, phytic acid or its salt, gluconic acid or its salt, galacturonic acid or its salt, galactaric acid or its salt, and combinations thereof. Claim 24 An antimicrobial composition according to claim 23, wherein the chelating agent is present and is caprylhydroxamic acid, a hydroxamate salt of caprylhydroxamic acid, or a combination thereof. Claim 25 delete Claim 26 delete Claim 27 delete Claim 28 delete Claim 29 delete Claim 30 delete Claim 31 delete Claim 32 delete Claim 33 delete Claim 34 delete Claim 35 delete Claim 36 delete Claim 37 delete Claim 38 delete
Citation Information
Patent Citations
Glycidyl ether from alcohol and epichlorohydrin
US5420312A
Surfactants derived from oligolycerols
WO2013062679A1
Alkoxylated secondary alcohol
WO2019092366A1
